Tranzactioneaza Achieve Life Science Inc (consolidare) (US.ACHVc) - 5.33 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 5.2400 USD
Ask 5.3900 USD
Minim 5.4000 USD
Maxim 5.4000 USD
Pret referinta 4.3800
Volum -
Volum ultima zi 1
Max 52 sapt -
Min 52 sapt -

Descriere companie

Achieve Life Sciences, Inc. (http://achievelifesciences.com/) is a clinical-stage pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid from the seeds of the Laburnum anagyroides plant. Cytisinicline is structurally similar to nicotine and a mechanism of action that is both agonistic and antagonistic. It is aid in smoking cessation, or nicotine addiction, by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms through agonistic effects on nicotine receptors and by reducing the reward and satisfaction associated with nicotine through antagonistic properties.

Informatii companie

Nume

ACHIEVE LIFE SCIENCE INC (consolidare)